Advances in pathogenesis and minimally invasive therapies for extrahepatic portal biliopathy
-
摘要: 门静脉性胆道病(PB)可累及整个胆道系统,主要介绍了累及肝外胆管、胆囊管及胆囊的肝外型PB。该病临床较为少见,多数医生对其认识不足。由于该病累及丰富的血管系统及精细的胆道系统,因此其治疗方案的选择应极其慎重,错误的治疗方案极易出现大出血及胆道损伤,加重患者病情,甚至危及患者生命。目前国际上尚无标准的PB治疗流程图。内镜微创治疗及外科介入治疗为临床常用的微创治疗方法。综述了PB的发病机制及目前临床应用的微创治疗方法,以期为该病的科学诊治提供依据。Abstract: Portal biliopathy (PB) can involve the whole biliary system and this article mainly introduces extrahepatic PB that involves the extrahepatic bile duct, the cystic duct, and the gallbladder. This disease is relatively rare in clinical practice, and most doctors do not have enough knowledge of this disease. Since this disease involves the rich vascular systems and the fine biliary system, its therapeutic regimens should be selected carefully; improper therapeutic regimens may easily cause massive hemorrhage and bile duct injury, make patients' conditions worse, and even threaten their lives. At present, there is still no standard flow chart for the treatment of PB around the world. Endoscopic therapy and surgical interventional treatment are commonly used minimally invasive therapies in clinical practice. This article reviews the pathogenesis of PB and minimally invasive therapies currently used in clinical practice, in order to provide a basis for scientific diagnosis and treatment of this disease.
-
Key words:
- biliary tract diseases /
- therapy /
- surgical procedures, minimally invasive /
- review
-
[1]KHUROO MS, RATHER AA, KHUROO NS, et al.Portal biliopathy[J].World J Gastroenterol, 2016, 22 (35) :7973-7982. [2]DHIMAN RK, SARASWAT VA, VALLA DC, et al.Portal cavernoma cholangiopathy:consensus statement of a working party of the Indian national association for study of the liver[J].J Clin Exp Hepatol, 2014, 4 (Suppl 1) :s2-s14. [3]SARASWAT VA, RAI P, KUMAR T, et al.Endoscopic management of portal cavernoma cholangiopathy:practice, principles and strategy[J].J Clin Exp Hepatol, 2014, 4 (Suppl 1) :s67-s76. [4]FRANCESCHET I, ZANETTO A, FERRARESE A, et al.Therapeutic approaches for portal biliopathy:a systematic review[J].World J Gastroenterol, 2016, 22 (45) :9909-9920. [5]LIU YB, HOU BH, CHEN R, et al.Biliary collateral veins and associated biliary abnormalities of portal hypertensive biliopathy in patients with cavernous transformation of portal vein[J].Clin Imaging, 2015, 39 (5) :841-844. [6]OO YH, OLLIFF S, HAYDON G, et al.Symptomatic portal biliopathy:a single centre experience from the UK[J].Eur J Gastroenterol Hepatol, 2009, 21 (2) :206-213. [7]LOURENO LC, HORTA DV, RODRIGUES CG, et al.Pseudocholangiocarcinoma sign:management of portal cavernoma biliopathy with fully-covered self-expandable metal stent[J].Clin Endosc, 2017.[Epub ahead of print] [8]LAYEC S, D'HALLUIN PN, PAGENAULT M, et al.Massive hemobilia during extraction of a covered self-expandable metal stent in a patient with portal hypertensive biliopathy[J].Gastrointest Endosc, 2009, 70 (3) :555-556. [9]GRGL A, KAYHAN B, DOGAN I, et al.Disappearance of the pseudocholangiocarcinoma sign after TIPSS[J].Am J Gastroenterol, 1996, 91 (1) :150-154. [10]HYUN D, PARK KB, LIM SJ, et al.Portal Vein Stenting for Portal Biliopathy with Jaundice[J].Cardiovasc Intervent Radiol, 2016, 39 (4) :620-623. [11]LLOP E, de JUAN C, SEIJO S, et al.Portal cholangiopathy:radiological classification and natural history[J].Gut, 2011, 60 (6) :853-860.
本文二维码
计量
- 文章访问数: 1795
- HTML全文浏览量: 11
- PDF下载量: 516
- 被引次数: 0